Junji Kawada, Minami Maruyama, Tomonori Nomura, Manatsu Mizuno, Akio Fukada, Shinya Kidogami, Yoshiki Taniguchi, Kei Asukai, Hideki Osawa, Yukako Mokutani, Tomoya Kishimoto, Hajime Hirose, Ho Min Kim, Shinichi Yoshioka, Yo Sasaki
{"title":"[Analysis of Short-Term Results after Introduction of Robotic Gastrectomy for Gastric Cancer at Our Hospital].","authors":"Junji Kawada, Minami Maruyama, Tomonori Nomura, Manatsu Mizuno, Akio Fukada, Shinya Kidogami, Yoshiki Taniguchi, Kei Asukai, Hideki Osawa, Yukako Mokutani, Tomoya Kishimoto, Hajime Hirose, Ho Min Kim, Shinichi Yoshioka, Yo Sasaki","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Robotic gastrectomy(RG)for gastric cancer(GC)has been covered by health insurance since 2018. In this study, we examined the results of RG for GC at our hospital during the initial period of its introduction.</p><p><strong>Materials and method: </strong>From August 2022 to May 2023, we retrospectively examined the surgical outcomes and short-term postoperative outcomes of the first 9 patients who underwent RG for GC at our hospital.</p><p><strong>Results: </strong>The median patient age was 77(67-82) years, gender was 4 males and 5 females, and distal gastrectomy was performed in all patients. The median operative time was 410(323-486)min, blood loss was 5(1-140)mL, postoperative hospital stay was less than 9 days in all patients, and there was no conversion to laparoscopic or open surgery. There were no postoperative complications of Clavien-Dindo Grade Ⅱ or above.</p><p><strong>Conclusion: </strong>In this study, RG for GC was performed safely without intraoperative or postoperative complications.</p>","PeriodicalId":35588,"journal":{"name":"Japanese Journal of Cancer and Chemotherapy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese Journal of Cancer and Chemotherapy","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Robotic gastrectomy(RG)for gastric cancer(GC)has been covered by health insurance since 2018. In this study, we examined the results of RG for GC at our hospital during the initial period of its introduction.
Materials and method: From August 2022 to May 2023, we retrospectively examined the surgical outcomes and short-term postoperative outcomes of the first 9 patients who underwent RG for GC at our hospital.
Results: The median patient age was 77(67-82) years, gender was 4 males and 5 females, and distal gastrectomy was performed in all patients. The median operative time was 410(323-486)min, blood loss was 5(1-140)mL, postoperative hospital stay was less than 9 days in all patients, and there was no conversion to laparoscopic or open surgery. There were no postoperative complications of Clavien-Dindo Grade Ⅱ or above.
Conclusion: In this study, RG for GC was performed safely without intraoperative or postoperative complications.